Cellectar Biosciences, Inc. (CLRB) has a market capitalization of $9.42M and trades at $2.95. The 52-week range is 2.43-20.7.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.4, Earnings Per Share (EPS) of $-8.35.
The stock has a beta of 0.40, operates in the Healthcare sector.
